Annual Reports

 
Quarterly Reports

  • 10-Q (Sep 1, 2017)
  • 10-Q (Mar 3, 2017)
  • 10-Q (Dec 5, 2016)
  • 10-Q (Sep 7, 2016)
  • 10-Q (Mar 9, 2016)
  • 10-Q (Dec 9, 2015)

 
8-K

 
Other

Medtronic 10-Q 2010

Documents found in this filing:

  1. 10-Q/A
  2. Graphic
  3. Graphic
MEDTRONIC, INC. FORM 10-Q FOR THE QUARTER ENDED JULY 30, 2010
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 10-Q/A
(Amendment No. 1)

 

 

x

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 30, 2010

Commission File Number 1-7707

(MEDTRONIC LOGO)

MEDTRONIC, INC.
(Exact name of registrant as specified in its charter)

 

 

 

Minnesota

 

41-0793183

(State of incorporation)

 

(I.R.S. Employer

 

 

Identification No.)

710 Medtronic Parkway
Minneapolis, Minnesota 55432
(Address of principal executive offices) (Zip Code)

(763) 514-4000
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.     Yes   x      No   o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x   No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

 

 

 

 

Large accelerated filer x

Accelerated filer o

 

 

Non-accelerated filer o

Smaller Reporting Company o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o   No x

Shares of common stock, $.10 par value, outstanding on September 3, 2010: 1,079,885,995

 
 


Explanatory Note

      The sole purpose of this Amendment No. 1 to our Quarterly Report on Form 10-Q for the period ended July 30, 2010 (the Form 10-Q), is to file Exhibit 101 to the Form 10-Q. Exhibit 101 consists of the following materials from Medtronic, Inc.’s Form 10-Q for the period ended July 30, 2010, filed with the Securities and Exchange Commission (SEC) on September 8, 2010, formatted in eXtensible Business Reporting Language (XBRL): (i) the unaudited Condensed Consolidated Balance Sheets; (ii) the unaudited Condensed Consolidated Statements of Earnings; (iii) the unaudited Condensed Consolidated Statements of Cash Flows; and (iv) the unaudited Notes to the Condensed Consolidated Financial Statements.

      This Amendment No. 1 does not reflect subsequent events occurring after the original filing date of the Form 10-Q or modify or update in any way disclosures made in the Form 10-Q.

      Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.








2




Item 6. Exhibits

 

 

 

(a)

Exhibits

 

 

 

 

12.1*

Medtronic, Inc. Computation of Ratio of Earnings to Fixed Charges.

 

 

 

 

31.1*

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

31.2*

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

32.1*

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

32.2*

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

101.INS**

XBRL Instance Document

 

 

 

 

101.SCH**

XBRL Schema Document

 

 

 

 

101.CAL**

XBRL Calculation Linkbase Document

 

 

 

 

101.DEF**

XBRL Definition Linkbase Document

 

 

 

 

101.LAB**

XBRL Label Linkbase Document

 

 

 

 

101.PRE**

XBRL Presentation Linkbase Document


 

 

 

 

 

*

Previously filed or furnished, as applicable, with our Form 10-Q as filed on September 8, 2010

 

**

Furnished with this Form 10-Q/A





3


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

Medtronic, Inc.

 

(Registrant)

 

 

Date: September 24, 2010

/s/ William A. Hawkins

 

William A. Hawkins

 

Chairman and Chief Executive Officer

 

 

Date: September 24, 2010

/s/ Gary L. Ellis

 

Gary L. Ellis

 

Senior Vice President and

 

Chief Financial Officer






4


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki